Cargando…
A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer
OBJECTIVE: Investigate the relationship between serum α-tocopherol concentration and long-term risk of prostate cancer, and evaluate the interaction with vitamin E–related genetic variants and their polygenic risk score (PRS). METHODS: We conducted a biochemical analysis of 29 102 male Finnish smoke...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391251/ https://www.ncbi.nlm.nih.gov/pubmed/35197557 http://dx.doi.org/10.1038/s41391-022-00511-y |
_version_ | 1784770832783900672 |
---|---|
author | Lawrence, Wayne R. Lim, Jung-eun Huang, Jiaqi Weinstein, Stephanie J. Mӓnnistӧ, Satu Albanes, Demetrius |
author_facet | Lawrence, Wayne R. Lim, Jung-eun Huang, Jiaqi Weinstein, Stephanie J. Mӓnnistӧ, Satu Albanes, Demetrius |
author_sort | Lawrence, Wayne R. |
collection | PubMed |
description | OBJECTIVE: Investigate the relationship between serum α-tocopherol concentration and long-term risk of prostate cancer, and evaluate the interaction with vitamin E–related genetic variants and their polygenic risk score (PRS). METHODS: We conducted a biochemical analysis of 29 102 male Finnish smokers in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Serum α-tocopherol was measured at baseline using high-performance liquid chromatography, and 2 724 prostate cancer cases were identified during 28 years of follow-up. Cox proportional hazards models examined whether serum α-tocopherol concentrations were associated with prostate cancer risk. Among 8 383 participants, three SNPs related to vitamin E status (rs964184, rs2108622, and rs11057830) were examined to determine whether they modified the relationship between serum α-tocopherol concentrations and prostate cancer risk, both individually and as a PRS using logistic regression models. RESULTS: No association was observed between serum α-tocopherol and prostate cancer risk (fifth quintile (Q5) versus Q1 hazard ratio (HR)=0.87, 95% confidence interval (95% CI) 0.75, 1.02; p-trend=0.57). Though no interactions were seen by population characteristics, high α-tocopherol concentration was associated with reduced prostate cancer risk among the trial α-tocopherol supplementation group (Q5 quintile versus Q1 HR=0.79, 95% CI 0.64, 0.99). Finally, no associated interaction between the three SNPs or their PRS and prostate cancer risk was observed. CONCLUSION: Although there was a weak inverse association between α-tocopherol concentration and prostate cancer risk over nearly three decades, our findings suggest that men receiving the trial α-tocopherol supplementation who had higher baseline serum α-tocopherol concentration experienced reduced prostate cancer risk. Vitamin E–related genotypes did not modify the serum α-tocopherol-prostate cancer risk association. |
format | Online Article Text |
id | pubmed-9391251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-93912512022-08-23 A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer Lawrence, Wayne R. Lim, Jung-eun Huang, Jiaqi Weinstein, Stephanie J. Mӓnnistӧ, Satu Albanes, Demetrius Prostate Cancer Prostatic Dis Article OBJECTIVE: Investigate the relationship between serum α-tocopherol concentration and long-term risk of prostate cancer, and evaluate the interaction with vitamin E–related genetic variants and their polygenic risk score (PRS). METHODS: We conducted a biochemical analysis of 29 102 male Finnish smokers in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Serum α-tocopherol was measured at baseline using high-performance liquid chromatography, and 2 724 prostate cancer cases were identified during 28 years of follow-up. Cox proportional hazards models examined whether serum α-tocopherol concentrations were associated with prostate cancer risk. Among 8 383 participants, three SNPs related to vitamin E status (rs964184, rs2108622, and rs11057830) were examined to determine whether they modified the relationship between serum α-tocopherol concentrations and prostate cancer risk, both individually and as a PRS using logistic regression models. RESULTS: No association was observed between serum α-tocopherol and prostate cancer risk (fifth quintile (Q5) versus Q1 hazard ratio (HR)=0.87, 95% confidence interval (95% CI) 0.75, 1.02; p-trend=0.57). Though no interactions were seen by population characteristics, high α-tocopherol concentration was associated with reduced prostate cancer risk among the trial α-tocopherol supplementation group (Q5 quintile versus Q1 HR=0.79, 95% CI 0.64, 0.99). Finally, no associated interaction between the three SNPs or their PRS and prostate cancer risk was observed. CONCLUSION: Although there was a weak inverse association between α-tocopherol concentration and prostate cancer risk over nearly three decades, our findings suggest that men receiving the trial α-tocopherol supplementation who had higher baseline serum α-tocopherol concentration experienced reduced prostate cancer risk. Vitamin E–related genotypes did not modify the serum α-tocopherol-prostate cancer risk association. 2022-09 2022-02-23 /pmc/articles/PMC9391251/ /pubmed/35197557 http://dx.doi.org/10.1038/s41391-022-00511-y Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms |
spellingShingle | Article Lawrence, Wayne R. Lim, Jung-eun Huang, Jiaqi Weinstein, Stephanie J. Mӓnnistӧ, Satu Albanes, Demetrius A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer |
title | A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer |
title_full | A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer |
title_fullStr | A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer |
title_full_unstemmed | A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer |
title_short | A 28-Year Prospective Analysis of Serum Vitamin E, Vitamin E-Related Genetic Variation and Risk of Prostate Cancer |
title_sort | 28-year prospective analysis of serum vitamin e, vitamin e-related genetic variation and risk of prostate cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391251/ https://www.ncbi.nlm.nih.gov/pubmed/35197557 http://dx.doi.org/10.1038/s41391-022-00511-y |
work_keys_str_mv | AT lawrencewayner a28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT limjungeun a28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT huangjiaqi a28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT weinsteinstephaniej a28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT männistösatu a28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT albanesdemetrius a28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT lawrencewayner 28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT limjungeun 28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT huangjiaqi 28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT weinsteinstephaniej 28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT männistösatu 28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer AT albanesdemetrius 28yearprospectiveanalysisofserumvitaminevitaminerelatedgeneticvariationandriskofprostatecancer |